Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3029% below fair value
$61.35−1.58 (-2.51%)
Close on Nov 17, 2026Market cap $125.40BP/E 13.6Yield 4.06%
Bristol Myers Squibb gross margin
Gross margin is gross profit as a percentage of revenue.
Bristol Myers Squibb's gross margin for the twelve months ending Sep 30, 2026 was 69.2%. For fiscal 2025 it was 71.1%, against 71.1% the year before. The highest annual figure on record is 78.6% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.1% | +0.0 |
| FY2024 | Dec 31, 2024 | 71.1% | −5.2 |
| FY2023 | Dec 31, 2023 | 76.2% | −1.8 |
| FY2022 | Dec 31, 2022 | 78.0% | −0.5 |
| FY2021 | Dec 31, 2021 | 78.6% | +6.3 |
| FY2020 | Dec 31, 2020 | 72.3% | +3.2 |
| FY2019 | Dec 31, 2019 | 69.1% | −2.2 |
| FY2018 | Dec 31, 2018 | 71.3% | +0.7 |
| FY2017 | Dec 31, 2017 | 70.7% | −3.9 |
| FY2016 | Dec 31, 2016 | 74.5% | −1.9 |
| FY2015 | Dec 31, 2015 | 76.4% | +1.2 |
| FY2014 | Dec 31, 2014 | 75.2% | +3.4 |
| FY2013 | Dec 31, 2013 | 71.8% | −2.0 |
| FY2012 | Dec 31, 2012 | 73.8% | +0.2 |
| FY2011 | Dec 31, 2011 | 73.6% | +0.7 |
| FY2010 | Dec 31, 2010 | 72.9% | +0.2 |
| FY2009 | Dec 31, 2009 | 72.7% | +2.7 |
| FY2008 | Dec 31, 2008 | 70.0% | +1.5 |
| FY2007 | Dec 31, 2007 | 68.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 68.3% | −3.6 |
| Q2 FY2026 | Jun 30, 2026 | 71.3% | −1.2 |
| Q1 FY2026 | Mar 31, 2026 | 70.2% | −2.7 |
| Q4 FY2025 | Dec 31, 2025 | 67.2% | +6.2 |
| Q3 FY2025 | Sep 30, 2025 | 71.9% | −3.2 |
| Q2 FY2025 | Jun 30, 2025 | 72.5% | −0.7 |
| Q1 FY2025 | Mar 31, 2025 | 72.9% | −2.4 |
| Q4 FY2024 | Dec 31, 2024 | 61.0% | −15.1 |
| Q3 FY2024 | Sep 30, 2024 | 75.1% | −2.0 |
| Q2 FY2024 | Jun 30, 2024 | 73.2% | −1.2 |
| Q1 FY2024 | Mar 31, 2024 | 75.3% | −2.1 |
| Q4 FY2023 | Dec 31, 2023 | 76.1% | −1.2 |
| Q3 FY2023 | Sep 30, 2023 | 77.1% | −1.9 |
| Q2 FY2023 | Jun 30, 2023 | 74.4% | −2.7 |
| Q1 FY2023 | Mar 31, 2023 | 77.4% | −1.4 |
| Q4 FY2022 | Dec 31, 2022 | 77.3% | −3.1 |
| Q3 FY2022 | Sep 30, 2022 | 79.0% | −1.3 |
| Q2 FY2022 | Jun 30, 2022 | 77.1% | −1.9 |
| Q1 FY2022 | Mar 31, 2022 | 78.8% | +4.4 |
| Q4 FY2021 | Dec 31, 2021 | 80.3% | +6.6 |
| Q3 FY2021 | Sep 30, 2021 | 80.3% | +4.0 |
| Q2 FY2021 | Jun 30, 2021 | 79.0% | +5.7 |
| Q1 FY2021 | Mar 31, 2021 | 74.3% | +8.3 |
| Q4 FY2020 | Dec 31, 2020 | 73.7% | +5.1 |
| Q3 FY2020 | Sep 30, 2020 | 76.3% | +6.1 |
| Q2 FY2020 | Jun 30, 2020 | 73.4% | +4.8 |
| Q1 FY2020 | Mar 31, 2020 | 66.0% | −3.2 |
| Q4 FY2019 | Dec 31, 2019 | 68.6% | −3.4 |
| Q3 FY2019 | Sep 30, 2019 | 70.2% | −1.2 |
| Q2 FY2019 | Jun 30, 2019 | 68.6% | −3.3 |
| Q1 FY2019 | Mar 31, 2019 | 69.2% | −0.7 |
| Q4 FY2018 | Dec 31, 2018 | 72.0% | +2.9 |
| Q3 FY2018 | Sep 30, 2018 | 71.4% | +1.4 |
| Q2 FY2018 | Jun 30, 2018 | 71.9% | +2.4 |
| Q1 FY2018 | Mar 31, 2018 | 69.9% | −4.5 |
| Q4 FY2017 | Dec 31, 2017 | 69.2% | −4.5 |
| Q3 FY2017 | Sep 30, 2017 | 69.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 69.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 74.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 73.6% | – |
See a number that looks wrong?